Related Experiment Videos
Cdk5 and Trio modulate endocrine cell exocytosis
Xiaonan Xin1, Francesco Ferraro, Nils Bäck
1Department of Neuroscience, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030, USA.
Journal of Cell Science
|August 28, 2004
Summary
Roscovitine, a cyclin-dependent kinase 5 (Cdk5) inhibitor, reduces pituitary hormone secretion by altering actin cytoskeleton dynamics. This involves Cdk5-mediated activation of Trio, a RhoGEF, impacting secretory granule exocytosis.
Area of Science:
- Endocrinology
- Cell Biology
- Molecular Biology
Background:
- Pituitary hormone secretion is crucial for endocrine function.
- The actin cytoskeleton plays a key role in regulating exocytosis and endocytosis.
- Cyclin-dependent kinase 5 (Cdk5) is implicated in various cellular processes.
Purpose of the Study:
- To investigate the role of Cdk5 in regulating pituitary hormone secretion.
- To elucidate the molecular mechanisms by which Cdk5 affects the actin cytoskeleton and exocytosis.
- To identify potential interactions between Cdk5, Trio, and secretory granule trafficking.
Main Methods:
- Utilized roscovitine as a Cdk5 inhibitor in pituitary cell models.
- Performed ultrastructural analysis to examine secretory granule dynamics.
- Investigated protein-protein interactions between Trio and peptidylglycine alpha-amidating monooxygenase.
- Assessed the effect of roscovitine on Trio-mediated Rac activation.
Main Results:
- Roscovitine treatment decreased pituitary hormone secretion.
- Roscovitine reorganized the cortical actin cytoskeleton, limiting secretory granule-plasma membrane interactions.
- Trio, a RhoGEF, was found to interact with a secretory granule protein.
- Cdk5 phosphorylates Trio at consensus sites, inhibiting Trio's ability to activate Rac.
Conclusions:
- Cdk5-mediated activation of Trio is involved in regulating the cortical actin cytoskeleton.
- This regulation by Cdk5 and Trio impacts hormone exocytosis and endocytosis in pituitary cells.
- The findings reveal a novel molecular pathway controlling pituitary hormone release.